Latest Articles

Publication Date
Liam Lawson & Isack Hadjar | Blue Square Endometriosis (MmxwoG2DiP) - Mshale

Liam Lawson & Isack Hadjar | Blue Square Endometriosis (MmxwoG2DiP) Mshale

Published: June 20, 2026, 7:03 a.m.
We Tried Living In Alicante… Here’s The Truth 🇪🇸 Endometriosis (vUlATyZoNx) - Mshale

We Tried Living In Alicante… Here’s The Truth 🇪🇸 Endometriosis (vUlATyZoNx) Mshale

Published: June 20, 2026, 6:58 a.m.
Rectovaginal Endometriosis: The Role of Pelvic Examination in Initiating a Multidisciplinary Approach.

Published: June 20, 2026, midnight
Hormonal Imbalance and Gut Dysbiosis: Emerging Perspectives in Women's Health.

The gut microbiota plays a crucial function in reproductive well-being and is vital for maintaining fundamental physiological balance. This article surveys the mutual relationships between the gut flora and the …

Published: June 20, 2026, midnight
Path beyond the blind end-unravel the imaging spectrum of appendiceal pathologies.

The appendix is involved in a diverse spectrum of inflammatory, infectious, benign, and malignant conditions that extend far beyond acute appendicitis. Although acute appendicitis remains the most common appendiceal emergency, …

Published: June 20, 2026, midnight
Validation of Endometriosis Fertility Index for the Prediction of Non-Assisted Reproductive Technology (ART) Pregnancy in Women With Endometriosis-Associated Infertility: A Prospective Cohort Study - Cureus

Validation of Endometriosis Fertility Index for the Prediction of Non-Assisted Reproductive Technology (ART) Pregnancy in Women With Endometriosis-Associated Infertility: A Prospective Cohort Study Cureus

Published: June 19, 2026, 10:11 p.m.
Huelga💔 - Anuel AA & Sr. Tortuga(IANOVATo) Endometriosis (pf2fYm1ipV) - Mshale

Huelga💔 - Anuel AA & Sr. Tortuga(IANOVATo) Endometriosis (pf2fYm1ipV) Mshale

Published: June 19, 2026, 7:04 p.m.
Nivolumab Produces 68% Clinical CR Rate in Resectable dMMR Endometrial Cancer - OncLive

Nivolumab Produces 68% Clinical CR Rate in Resectable dMMR Endometrial Cancer OncLive

Published: June 19, 2026, 5:49 p.m.
Puxitatug Samrotecan Hits 60% Response Rate in Platinum- and IO-Pretreated Endometrial Cancer - Targeted Oncology

Puxitatug Samrotecan Hits 60% Response Rate in Platinum- and IO-Pretreated Endometrial Cancer Targeted Oncology

Published: June 19, 2026, 5:05 p.m.
Endometriosis and fibroids: Expert explains advances giving women less invasive treatment options - The Union Democrat

Endometriosis and fibroids: Expert explains advances giving women less invasive treatment options The Union Democrat

Published: June 19, 2026, 4:24 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!